Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics.

Zhang J, Wang J, Luan T, Zuo Y, Chen J, Zhang H, Ye Z, Wang H, Hai B.

Oncol Rep. 2019 Jun;41(6):3292-3304. doi: 10.3892/or.2019.7131. Epub 2019 Apr 18.

2.
3.

IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line.

Furuta H, Yoshihara H, Fukushima T, Yoneyama Y, Ito A, Worrall C, Girnita A, Girnita L, Yoshida M, Asano T, Komada M, Kataoka N, Chida K, Hakuno F, Takahashi SI.

Oncotarget. 2018 Sep 21;9(74):33871-33883. doi: 10.18632/oncotarget.26049. eCollection 2018 Sep 21.

4.

LASS2 regulates invasion and chemoresistance via ERK/Drp1 modulated mitochondrial dynamics in bladder cancer cells.

Huang L, Luan T, Chen Y, Bao X, Huang Y, Fu S, Wang H, Wang J.

J Cancer. 2018 Feb 28;9(6):1017-1024. doi: 10.7150/jca.23087. eCollection 2018.

5.

Deubiquitinase USP9X promotes cell migration, invasion and inhibits apoptosis of human pancreatic cancer.

Liu L, Yao D, Zhang P, Ding W, Zhang X, Zhang C, Gong S, Zhang Y, Wang J, Sun T, Ren Z.

Oncol Rep. 2017 Dec;38(6):3531-3537. doi: 10.3892/or.2017.6050. Epub 2017 Oct 20.

PMID:
29130109
6.

Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway.

Sun X, Lin L, Chen Y, Liu T, Liu R, Wang Z, Mou K, Xu J, Li B, Song H.

Mol Med Rep. 2016 Apr;13(4):3161-8. doi: 10.3892/mmr.2016.4929. Epub 2016 Feb 23.

PMID:
26935265
7.

Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression.

Zhu F, Liu P, Li J, Zhang Y.

Oncol Rep. 2014 May;31(5):2049-54. doi: 10.3892/or.2014.3060. Epub 2014 Mar 5.

PMID:
24604010
8.

Aquaporin 3 promotes prostate cancer cell motility and invasion via extracellular signal-regulated kinase 1/2-mediated matrix metalloproteinase-3 secretion.

Chen J, Wang Z, Xu D, Liu Y, Gao Y.

Mol Med Rep. 2015 Apr;11(4):2882-8. doi: 10.3892/mmr.2014.3097. Epub 2014 Dec 16.

PMID:
25515250
9.

miR-132 suppresses the migration and invasion of lung cancer cells by blocking USP9X-induced epithelial-mesenchymal transition.

Guo H, Zhang X, Chen Q, Bao Y, Dong C, Wang X.

Am J Transl Res. 2018 Jan 15;10(1):224-234. eCollection 2018.

10.

Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9.

Song H, Li Y, Lee J, Schwartz AL, Bu G.

Cancer Res. 2009 Feb 1;69(3):879-86. doi: 10.1158/0008-5472.CAN-08-3379. Epub 2009 Jan 27.

11.

CT45A1 siRNA silencing suppresses the proliferation, metastasis and invasion of lung cancer cells by downregulating the ERK/CREB signaling pathway.

Tang F, Tang S, Guo X, Yang C, Jia K.

Mol Med Rep. 2017 Nov;16(5):6708-6714. doi: 10.3892/mmr.2017.7466. Epub 2017 Sep 12.

12.

Reduced ubiquitin-specific protease 9X expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cells.

Hu H, Tang C, Jiang Q, Luo W, Liu J, Wei X, Liu R, Wu Z.

Oncol Lett. 2015 Jul;10(1):268-272. Epub 2015 Apr 27.

13.

Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.

Ding G, Fang J, Tong S, Qu L, Jiang H, Ding Q, Liu J.

Prostate. 2015 Jun 15;75(9):957-68. doi: 10.1002/pros.22978. Epub 2015 Feb 25.

PMID:
25728945
14.

TBX2 overexpression promotes proliferation and invasion through epithelial-mesenchymal transition and ERK signaling pathway.

Liu X, Miao Z, Wang Z, Zhao T, Xu Y, Song Y, Huang J, Zhang J, Xu H, Wu J, Xu H.

Exp Ther Med. 2019 Jan;17(1):723-729. doi: 10.3892/etm.2018.7028. Epub 2018 Nov 28.

15.

Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-κB.

Dilly AK, Ekambaram P, Guo Y, Cai Y, Tucker SC, Fridman R, Kandouz M, Honn KV.

Int J Cancer. 2013 Oct 15;133(8):1784-91. doi: 10.1002/ijc.28165. Epub 2013 Jul 13.

16.

Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.

Moro L, Arbini AA, Yao JL, di Sant'Agnese PA, Marra E, Greco M.

Cancer Sci. 2008 Mar;99(3):553-63. doi: 10.1111/j.1349-7006.2007.00719.x. Epub 2007 Dec 27. Erratum in: Cancer Sci. 2014 Jul;105(7):932.

17.

USP9X deubiquitinates ALDH1A3 and maintains mesenchymal identity in glioblastoma stem cells.

Chen Z, Wang HW, Wang S, Fan L, Feng S, Cai X, Peng C, Wu X, Lu J, Chen D, Chen Y, Wu W, Lu D, Liu N, You Y, Wang H.

J Clin Invest. 2019 Apr 8;130:2043-2055. doi: 10.1172/JCI126414. eCollection 2019 Apr 8.

18.

CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling.

Kato T, Fujita Y, Nakane K, Mizutani K, Terazawa R, Ehara H, Kanimoto Y, Kojima T, Nozawa Y, Deguchi T, Ito M.

Cytokine. 2013 Oct;64(1):251-7. doi: 10.1016/j.cyto.2013.06.313. Epub 2013 Jul 19.

PMID:
23876400
19.

S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.

Zhu W, Xue Y, Liang C, Zhang R, Zhang Z, Li H, Su D, Liang X, Zhang Y, Huang Q, Liu M, Li L, Li D, Zhao AZ, Liu Y.

Tumour Biol. 2016 Sep;37(9):12241-12250. Epub 2016 May 30.

PMID:
27240591
20.

[Expression of USP9X in Non-small Cell Lung Cancer and Its Clinical Significance].

Peng J, Hu Q, Liu WP, Liu SL, Wang H.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2015 May;46(3):413-6. Chinese.

PMID:
26121864

Supplemental Content

Support Center